Back to Results
First PageMeta Content
Thalassemia / Clinical trial / Beta-thalassemia / Sickle-cell disease / Health / Medicine / Science


Microsoft Word - HemaQuest Pharmaceuticals Receives Additional $4M in Funding _7-28-2010_
Add to Reading List

Document Date: 2011-08-15 11:58:29


Open Document

File Size: 67,95 KB

Share Result on Facebook

City

SEATTLE / /

Company

Latterell Venture Partners / De Novo Ventures / HemaQuest Pharmaceuticals / Lilly Ventures / Forward Ventures / Aberdare Ventures / /

Currency

USD / /

Event

Funding / Employment Change / /

IndustryTerm

biopharmaceutical / therapies for serious and life threatening orphan diseases / stage biotechnology company developing small molecule therapeutics / fatty acid technologies / short chain / /

MedicalCondition

cancers / common hemoglobin disorders / hematologic diseases / sickle cell disease / beta thalassemia / orphan diseases / /

Person

Jim Woody / James Woody / Fred Dotzler / /

Position

General Partner / Managing Director / Chairman of the Board / board member / /

Product

Series B / /

Technology

biotechnology / fatty acid technologies / /

URL

www.HemaQuest.com / /

SocialTag